NasdaqGS - Delayed Quote • USD
Masimo Corporation (MASI)
At close: April 19 at 4:00 PM EDT
After hours: April 19 at 7:52 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 7 | 7 | 6 | 7 |
| Avg. Estimate | 0.69 | 0.77 | 3.52 | 3.91 |
| Low Estimate | 0.61 | 0.68 | 3.45 | 3.52 |
| High Estimate | 0.72 | 0.83 | 3.58 | 4.18 |
| Year Ago EPS | 0.87 | 0.62 | 3.17 | 3.52 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 7 | 8 | 9 | 9 |
| Avg. Estimate | 487.55M | 503.79M | 2.1B | 2.23B |
| Low Estimate | 480.1M | 493M | 2.06B | 2.17B |
| High Estimate | 490.7M | 513M | 2.12B | 2.28B |
| Year Ago Sales | 565M | 478.35M | 2.05B | 2.1B |
| Sales Growth (year/est) | -13.70% | 5.30% | 2.60% | 6.00% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | 0.83 | 0.56 | 0.59 | 0.88 |
| EPS Actual | 0.87 | 0.62 | 0.63 | 1.06 |
| Difference | 0.04 | 0.06 | 0.04 | 0.18 |
| Surprise % | 4.80% | 10.70% | 6.80% | 20.50% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0.69 | 0.77 | 3.52 | 3.91 |
| 7 Days Ago | 0.69 | 0.77 | 3.52 | 3.91 |
| 30 Days Ago | 0.69 | 0.77 | 3.52 | 3.91 |
| 60 Days Ago | 0.71 | 0.73 | 3.38 | 3.75 |
| 90 Days Ago | 0.72 | 0.7 | 3.15 | 3.62 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | 1 |
| Up Last 30 Days | 1 | 1 | 1 | 2 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | MASI | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -20.70% | -- | -- | 1.60% |
| Next Qtr. | 24.20% | -- | -- | 10.50% |
| Current Year | 11.00% | -- | -- | 5.20% |
| Next Year | 11.10% | -- | -- | 13.30% |
| Next 5 Years (per annum) | 11.90% | -- | -- | 11.22% |
| Past 5 Years (per annum) | 2.57% | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell
Earnings
Upgrades & Downgrades
| Upgrade | Stifel: Hold to Buy | 4/15/2024 |
| Maintains | BTIG: Buy to Buy | 3/25/2024 |
| Maintains | Stifel: Hold to Hold | 3/25/2024 |
| Upgrade | Wells Fargo: Equal-Weight to Overweight | 3/25/2024 |
| Maintains | Piper Sandler: Neutral to Neutral | 2/26/2024 |
| Downgrade | Jefferies: Buy to Hold | 1/30/2024 |
Related Tickers
NARI Inari Medical, Inc.
38.59
-0.13%
ITGR Integer Holdings Corporation
116.62
-1.03%
GMED Globus Medical, Inc.
50.35
-0.79%
PRCT PROCEPT BioRobotics Corporation
50.19
-1.74%
ALGN Align Technology, Inc.
298.98
-0.78%
DXCM DexCom, Inc.
130.71
-2.67%
PODD Insulet Corporation
166.25
+0.92%
SWAV Shockwave Medical, Inc.
329.00
+0.45%
OM Outset Medical, Inc.
2.3200
+3.11%
EW Edwards Lifesciences Corporation
85.94
-0.59%